- Home
- EVOK
EVOK
Evoke Pharma Inc.
as 07-26-2024 4:00pm EST
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | SOLANA BEACH |
| Market Cap: | 3.7M | IPO Year: | 2013 |
| Target Price: | N/A | AVG Volume (30 days): | 19.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.40 - $1.67 | Next Earning Date: | 08-08-2024 |
| Revenue: | $6,105,712 | Revenue Growth: | 110.49% |
| Revenue Growth (this year): | 169.31% | Revenue Growth (next year): | 60.13% |
Latest Evoke Pharma Inc. News
EVOK Breaking Stock News: Dive into EVOK Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
GlobeNewswire
2 months ago
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
GlobeNewswire
2 months ago
Evoke Pharma Reports First Quarter 2024 Financial Results
GlobeNewswire
3 months ago
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
GlobeNewswire
4 months ago
Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer
Simply Wall St.
4 months ago
Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?
Insider Monkey
4 months ago
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript
Thomson Reuters StreetEvents
4 months ago
Q4 2023 Evoke Pharma Inc Earnings Call
Compare EVOK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EVOK Evoke Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.